Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced new results from the Phase 3 PALISADE study and the open-label extension from the Phase 2 MUIR and SHASTA-2 studies of investigational ...

The results could influence how doctors approach cholesterol management in patients, Fiaklow said ... due to Alzheimer’s ...

Predicting who is at high risk for a heart attack or death may be as simple as obtaining a person's coronary artery calcium ...

Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed ...

The heart is one of the most vital organs, beating about 100,000 times a day, and pumping upwards of 2,000 gallons of blood ...

A prescription medication that has been available in the U.S. since 1992 might have another significant benefit.

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics ...

Amongst all the aids that exist in the maintenance of hypertension, diet is considered to be one of the most effective ...

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

Share on PinterestPopular diabetes drugs have been linked with a lower risk of experiencing a second stroke or a heart attack ...

Diabetes is a widespread condition that can lead to serious health issues when not managed well. One of the most concerning ...

Plozasiran specifically targets and reduce the production of APOC3, thereby reducing triglyceride levels and lowering the ...